KLRC1 (Gene)

Organism:

Homo sapiens

Synonyms:CD159A, ENTREZ:3821, HGNC:6374, KLRC1, MIM:161555, NKG2, NKG2A, NM_001304448, NM_002259, NM_007328, NM_213657, NM_213658, NP_001291377, NP_002250, NP_015567, NP_998822, NP_998823, XM_024448973, XP_024304741, killer cell lectin like receptor C1

Id:ENSG00000134545

Entrez:3821

Ensembl:ENSG00000134545

Description:killer cell lectin like receptor C1

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View KLRC1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with KLRC1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using KLRC1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for KLRC1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with KLRC1.

Results found

Linked to

	Label	Description
	GSE110709 GSK-J4 5 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE184892 trehalose fibroblast 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199862 Chk1 inhibition 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 gemcitabine 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 9 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE184892 7 V 3 TREHALOSE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 0 V 2 GEMCITABINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE154337 temozolomide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE125956 SYK knockdown 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE110709 GSK-J4 5 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE184892 trehalose fibroblast 7 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE199862 Chk1 inhibition 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE148200 gemcitabine 0 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 9 v 11 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE184892 7 V 3 TREHALOSE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE148200 0 V 2 GEMCITABINE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE154337 temozolomide 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE125956 SYK knockdown 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.